Forefront Analytics, LLC Dyadic International Inc Transaction History

Forefront Analytics, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.18 - $2.32 $19,526 - $38,391	16,548 Added 40.81%	57,094 $70,000
Q3 2022 Nov 14, 2022	SELL	$1.65 - $3.42 $10,271 - $21,289	-6,225 Reduced 13.31%	40,546 $77,000
Q2 2022 Aug 10, 2022	BUY	$1.85 - $3.22 $24,235 - $42,182	13,100 Added 38.91%	46,771 $143,000
Q1 2022 May 09, 2022	BUY	$3.01 - $4.81 $3,310 - $5,291	1,100 Added 3.38%	33,671 $102,000
Q4 2021 Feb 11, 2022	BUY	$3.36 - $5.34 $3,024 - $4,806	900 Added 2.84%	32,571 $147,000
Q3 2021 Nov 15, 2021	BUY	$3.3 - $6.49 $1,402 - $2,758	425 Added 1.36%	31,671 $178,000
Q2 2021 Aug 10, 2021	BUY	$3.35 - $5.67 $6,820 - $11,544	2,036 Added 6.97%	31,246 $112,000
Q1 2021 May 13, 2021	BUY	$4.75 - $6.87 $27,521 - $39,804	5,794 Added 24.74%	29,210 $161,000
Q4 2020 Feb 12, 2021	BUY	$5.35 - $7.77 $3,932 - $5,710	735 Added 3.24%	23,416 $124,000
Q3 2020 Nov 12, 2020	SELL	$7.22 - $9.11 $57,731 - $72,843	-7,996 Reduced 26.07%	22,681 $171,000
Q2 2020 Aug 10, 2020	BUY	$4.93 - $10.26 $149,364 - $310,847	30,297 Added 7972.89%	30,677 $266,000
Q1 2020 May 11, 2020	BUY	$2.58 - $6.6 $980 - $2,508	380 New	380 $1,000

4.68M

11.4K

Ticker DYAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,423,100
Market Cap $31.3M
Description
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

Stay updated on Forefront Analytics, LLC with notifications on news.